Sector
PharmaceuticalsOpen
₹1,089.3Prev. Close
₹1,111.5Turnover(Lac.)
₹30.47Day's High
₹1,089.3Day's Low
₹1,089.352 Week's High
₹1,87052 Week's Low
₹802Book Value
₹548.29Face Value
₹10Mkt Cap (₹ Cr.)
750.74P/E
28.13EPS
39.52Divi. Yield
0.0810 Jun 2024
12:00 AM
AGM
Announcement Date: 10 Jun, 2024
29 Apr 2024
12:00 AM
EGM
15 Apr 2025
12:00 AM
Board Meeting
Agenda : Audited Result
10 Jun 2024
12:00 AM
BookCloser
22 May 2024
12:00 AM
Dividend
Dividend Amount: 1
Record Date: 25 Jun, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 5.82 | 5.77 | 5.77 | 5.73 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 207.79 | 185.29 | 160.38 | 138.21 |
Net Worth | 213.61 | 191.06 | 166.15 | 143.94 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 203.66 | 226.32 | 136.32 | 111.22 |
yoy growth (%) | -10.01 | 66.01 | 22.56 | -7.1 |
Raw materials | -134.03 | -147.23 | -87.98 | -79.26 |
As % of sales | 65.8 | 65.05 | 64.53 | 71.26 |
Employee costs | -14.38 | -14.1 | -12.36 | -11.05 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 27.01 | 34.95 | 13.77 | 7.96 |
Depreciation | -6.02 | -5.88 | -5.57 | -5.79 |
Tax paid | -6.8 | -8.65 | -3.67 | -0.58 |
Working capital | -3.24 | 29.95 | 17.25 | -4.15 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -10.01 | 66.01 | 22.56 | -7.1 |
Op profit growth | -16.81 | 127.66 | 89.81 | -32.25 |
EBIT growth | -22.44 | 143.4 | 65.89 | -18.1 |
Net profit growth | -23.15 | 160.4 | 36.86 | 14.35 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 257.36 | 217.98 | 212.01 | 204.64 | 228.18 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 257.36 | 217.98 | 212.01 | 204.64 | 228.18 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 8.59 | 11.74 | 7.78 | 8.67 | 11.48 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,744.85 | 132.89 | 4,18,647.96 | 1,181.05 | 0.77 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,001.1 | 76.85 | 1,59,310.35 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,478.5 | 25.66 | 1,19,409.63 | 1,438.15 | 0.88 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,137.55 | 58.21 | 1,06,184.18 | 485 | 0.89 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,413.35 | 51.49 | 99,569.64 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Bharat Kumar R Desai
Executive Director
Hemang Jayendrabhai Shah
Non Executive Director
Shaileshkumar Ghabhawala
Independent Director
Zankhana Sheth
Independent Director
Mukesh Patel
Non Executive Director
Sanjay Shah
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Bharat Parenterals Ltd
Summary
Bharat Parenterals Ltd. was incorporated on Sep.92 in Gujarat and promoted by Ramesh Desai and Bharat Desai. The Company is engaged in the business of manufacturing drugs, pharmaceutical formulations and ayurvedic products at its plant in Baroda. It has set-up a fully integrated and modern plant as per WHO standards at Haripura near Baroda for manufacturing pharmaceutical formulations, life saving drugs, parenterals and antibiotics.In 2016, Varenyam Healthcare Private Limited was incorporated as wholly owned subsidiary company effective 09 July, 2016. Innoxel Lifesciences was incorporated as wholly owned subsidiary company effective 16th October, 2020. Varenyam Biolifesciences got incorporated as wholly owned subsidiary company effective 28th June, 2022.
Read More
What is the Bharat Parenterals Ltd share price today?
The Bharat Parenterals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹1089.3 today.
What is the Market Cap of Bharat Parenterals Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bharat Parenterals Ltd is ₹750.74 Cr. as of 09 May ‘25
What is the PE and PB ratio of Bharat Parenterals Ltd?
The PE and PB ratios of Bharat Parenterals Ltd is 28.13 and 2.03 as of 09 May ‘25
What is the 52 Week High and Low of Bharat Parenterals Ltd?
The 52-week high/low is the highest and lowest price at which a Bharat Parenterals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Bharat Parenterals Ltd is ₹802 and ₹1870 as of 09 May ‘25
What is the CAGR of Bharat Parenterals Ltd?
Bharat Parenterals Ltd's CAGR for 5 Years at 40.78%, 3 Years at 48.11%, 1 Year at -28.13%, 6 Month at -24.96%, 3 Month at -12.91% and 1 Month at 12.39%.
What is the shareholding pattern of Bharat Parenterals Ltd?
The shareholding pattern of Bharat Parenterals Ltd is as follows:
Promoters - 67.20 %
Institutions - 0.65 %
Public - 32.15 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
